| CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial JY Spiegel, S Patel, L Muffly, NM Hossain, J Oak, JH Baird, MJ Frank, ... Nature medicine 27 (8), 1419-1431, 2021 | 347 | 2021 |
| Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors AS Kanate, A Mussetti, MA Kharfan-Dabaja, KW Ahn, A DiGilio, ... Blood, The Journal of the American Society of Hematology 127 (7), 938-947, 2016 | 289 | 2016 |
| Rituximab resistance AR Rezvani, DG Maloney Best practice & research Clinical haematology 24 (2), 203-216, 2011 | 264 | 2011 |
| Allogeneic hematopoietic cell transplantation: the state of the art B Gyurkocza, A Rezvani, RF Storb Expert review of hematology 3 (3), 285-299, 2010 | 252 | 2010 |
| Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 242 | 2017 |
| Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma AR Rezvani, B Storer, M Maris, ML Sorror, E Agura, RT Maziarz, JC Wade, ... Journal of clinical oncology 26 (2), 211-217, 2008 | 230 | 2008 |
| The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation BL Scott, TA Gooley, ML Sorror, AR Rezvani, ML Linenberger, J Grim, ... Blood, The Journal of the American Society of Hematology 119 (11), 2657-2664, 2012 | 167 | 2012 |
| Autologous transplantation in follicular lymphoma with early therapy failure: a National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis C Casulo, JW Friedberg, KW Ahn, C Flowers, A DiGilio, SM Smith, ... Biology of blood and marrow transplantation 24 (6), 1163-1171, 2018 | 148 | 2018 |
| Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial EJ Fuchs, PV O’Donnell, M Eapen, B Logan, JH Antin, P Dawson, ... Blood, The Journal of the American Society of Hematology 137 (3), 420-428, 2021 | 146 | 2021 |
| Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: A multicentre experience AR Rezvani, L Norasetthada, T Gooley, M Sorror, ME Bouvier, F Sahebi, ... British journal of haematology 143 (3), 395-403, 2008 | 118 | 2008 |
| Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma JH Baird, DJ Epstein, JS Tamaresis, Z Ehlinger, JY Spiegel, J Craig, ... Blood advances 5 (1), 143-155, 2021 | 112 | 2021 |
| Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT CE Ryan, B Sahaf, AC Logan, S O’Brien, JC Byrd, P Hillmen, JR Brown, ... Blood, The Journal of the American Society of Hematology 128 (25), 2899-2908, 2016 | 90 | 2016 |
| Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis J Bolaños-Meade, M Hamadani, J Wu, MM Al Malki, MJ Martens, ... New England Journal of Medicine 388 (25), 2338-2348, 2023 | 89 | 2023 |
| Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation AR Rezvani, RF Storb Journal of autoimmunity 30 (3), 172-179, 2008 | 88 | 2008 |
| Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes AR Rezvani, JS McCune, BE Storer, A Batchelder, A Kida, HJ Deeg, ... Biology of Blood and Marrow Transplantation 19 (7), 1033-1039, 2013 | 80 | 2013 |
| Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study ME Horwitz, PJ Stiff, C Cutler, C Brunstein, R Hanna, RT Maziarz, ... Blood, The Journal of the American Society of Hematology 138 (16), 1429-1440, 2021 | 77 | 2021 |
| Microbiota manipulation with prebiotics and probiotics in patients undergoing stem cell transplantation TM Andermann, A Rezvani, AS Bhatt Current hematologic malignancy reports 11, 19-28, 2016 | 73 | 2016 |
| Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation AR Rezvani, BE Storer, RF Storb, M Mielcarek, DG Maloney, ... Biology of Blood and Marrow Transplantation 17 (11), 1594-1601, 2011 | 72 | 2011 |
| Impact of donor age on outcome after allogeneic hematopoietic cell transplantation AR Rezvani, BE Storer, KA Guthrie, HG Schoch, DG Maloney, ... Biology of Blood and Marrow Transplantation 21 (1), 105-112, 2015 | 68 | 2015 |
| Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients RF Yeh, MA Pawlikowski, DK Blough, GB McDonald, PV O’Donnell, ... Biology of Blood and Marrow Transplantation 18 (2), 265-272, 2012 | 66 | 2012 |
